Simplex LAB Spółka z Ograniczoną Odpowiedzialnością (KRS 0001078559, NIP 5242994455) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. SIMPLEX LAB operates in: Manufacture of medical and dental instruments and supplies (PKD 32.50.Z). Industry: Other manufacturing. The company has been listed in the National Court Register since January 4, 2024. SIMPLEX LAB's most recently reported net revenue was 164.1 K PLN for 2024.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Simplex LAB
Identity
- Name
- Simplex LAB Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- January 4, 2024
- Registry status as of
- December 3, 2025
- Latest entry
- July 14, 2025
- Founding act
- 28.12.2023
Articles of association history (2)
- December 28, 2023: 28.12.2023
- January 5, 2024: 05.01.2024 R. - ZMIANA § 2
Activities
Main activity
32.50.ZManufacture of medical and dental instruments and supplies
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. WOLIŃSKA, 4, 03-699, WARSZAWA, POLSKA
- Voivodeship
- MAZOWIECKIE
- District
- WARSZAWA
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 52.2298, 21.0117approx.
Risk and payment profile - Simplex LAB
Credibility rating
60 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
2
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
Spółka wykazuje sygnały niestabilności organizacyjnej: częste zmiany nazwy spółki. Może to wskazywać na podwyższone ryzyko współpracy.
Shareholder changes
0
0/2 yrs
Board changes
0
0/2 yrs
PKD changes
0
0/2 yrs
Name changes
1
1/2 yrs
Data from 2 years of registry activity.
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Simplex LAB
Founded
January 4, 2024
2 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
32.50.Z
Manufacture of medical and dental instruments and supplies
Share capital
5.0 K PLN
50 shares total
Shareholders
2
shareholders
Board
2 people
Filed years
1 year
2024
Registry entries
6
latest: July 14, 2025
Revenue
164.1 K PLN
2024
Net profit
11.4 K PLN
2024
Assets
36.2 K PLN
2024
Equity
16.4 K PLN
2024
Valuation
72.3 K PLN
Low confidence
Low confidence
Market comparison Simplex LAB
Comparison with PKD sector 32.50.Z
Market position (2024)
Sector median - total assets
Company - total assets
Public procurement
Trademarks
Reviews
Rate business credibility - Simplex LAB.
Related articles
News
Mennica Polska 2026: Q1 revenue +80% YoY (PLN 726.7 m), 838 kg of investment gold (+38%), Bulwary Praskie 95% sold, PLN 1.5 per share dividend
Warsaw-based Mennica Polska S.A. (KRS 0000019196), the only Polish producer of investment-gold bars with three independent business legs (minting, the City Card transit ticket, and the Bulwary Praskie real-estate developer), posted Q1 2026 revenue of PLN 726.7 m (+80% YoY vs PLN 402.9 m) and EBITDA of PLN 56.4 m (+28%). Investment-gold sales: 838 kg (+38% by weight YoY). 2025 closed with EBITDA of around PLN 160 m (+29%) and net profit of around PLN 500 m (a significant part from the developer segment). Bulwary Praskie: 747 apartments with occupancy permits, 95% sold or reserved. Recommended dividend: PLN 1.5 per share (PLN 76.5 m).
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
